Related Experiment Video
Updated: Jun 25, 2026

Isolated Lung Perfusion System in the Rabbit Model
Published on: July 15, 2021
Improvement of pulmonary microcirculation after lung transplantation using phosphodiesterase-5 inhibitor modified
Nikolaus Pizanis1, Jens Heckmann, Daniel Wendt
1Department of Thoracic and Cardiovascular Surgery, West German Heart Center Essen, University Hospital of Essen, Essen, Germany. Nikolaus.Pizanis@uni-essen.de
Objective:
Optimising the preservation modality and thus maintaining the post-transplanted organ function remains a point of interest in research in order to prevent deleterious ischaemia/reperfusion injury. Microcirculation allows the assessment of initial graft function before obvious functional parameters. It was the aim of our study to compare the effects of epoprostenol and sildenafil on the pulmonary microcirculation and haemodynamics, when used in the preservation solution in lung transplantation.
Methods:
Twenty-one pigs underwent single LuTx after 24h graft-ischaemia, preserved with buffered low potassium-dextran solution (I, control); with addition of 0.66 microg/kg/bw epoprostenol (II) or with 0.15 mg/kg/bw sildenafil (III). The pulmonary microcirculation, alveolar capillary diameter (ACD), red blood cell (RBC) velocity and functional capillary density (FCD), were assessed by intravital microscopy (OPS-imaging) hourly until 6h after reperfusion. Haemodynamics and blood gas exchange were monitored at all timepoints.
Results:
ACD was increased in group III directly after reperfusion (132+/-4.4% vs 121+/-3.1%, in % of baseline, III vs I; mean+/-SEM; p<0.05) and decreased during the experiment. RBC velocity did not reach statistical significance (256+/-93 vs 263+/-85 and 283+/-66 microm/s, III vs II and I; mean+/-SD). FCD in group III was higher than in I and II beginning 3h after reperfusion (10.1+/-1.4 vs 6.1+/-1.9 microm/microm(2), III vs I; mean+/-SEM; p<0.05).
Conclusions:
Our study demonstrated a significantly improved microcirculation after application of PDF V during organ procurement, probably because of better distribution of the preservation solution. Further studies are necessary, to prove the long-term effects of this observation.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

